Showing 141 - 160 results of 442 for search '"alcoholism"', query time: 0.07s Refine Results
  1. 141
  2. 142

    Product Innovation, Price Level And Competitive Advantage: A Perception Assessment Of Beer Products by Emenike O., Kalu, Olutayo, Osunsan, Moses, Agaba

    Published 2022
    Subjects: “…Product Innovation, Price Level, Competitive Advantage, Alcoholic Beverages.…”
    Get full text
    Article
  3. 143
  4. 144

    Effect of daily alcohol consumption and age over 40 years on COVID-19 vaccination antibody titers in the Delta era among hospital workers in northern Okinawa, Japan: A retrospective cohort study by Takuji Kishimoto, Daisuke Tasato, Yoshitaka Nagasawa, Akihiro Yamashiro, Hayashi Shokita

    Published 2025-02-01
    “…Conclusions: The results of this study indicate that shortening vaccination intervals for individuals over 40 years and discontinuing daily alcohol consumption are associated with the preservation of acquired antibody titers for optimizing vaccine efficacy.…”
    Get full text
    Article
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149
  10. 150
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156

    Factores de riesgo que influyen en la recaída de consumo de drogas lícitas e ilícitas en adolescentes atendidos en el Instituto sobre Alcoholismo y Farmacodependencia / Risk Factors Affecting Relapse of Licit and Illicit Drug Use in Adolescents Assisted by the Institute of Alcoholism and Drug Dependence (IAFA) by Tatiana Blanco-Álvarez, Silvia Jiménez-Morales

    Published 2015-12-01
    “…Sample: 107 adolescents receiving outpatient care at the Juvenile Center of the Institute on Alcoholism and Drug Dependence (IAFA). Conclusions: intrapersonal variables such as emotional regulation (goal-directed behavior), attentional control (focused attention), negative emotional states, and seeking positive sensations are risk factors that determine drug consumption relapse. …”
    Get full text
    Article
  17. 157

    Lipotoxicity and metabolic disorders at obesity by V. T. Ivashkin, M. V. Mayevskaya

    Published 2010-02-01
    Subjects: “…non-alcoholic fatty liver disease…”
    Get full text
    Article
  18. 158
  19. 159

    Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) by V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

    Published 2018-08-01
    “…To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and methods. Original study included overall 180 patients with nonalcoholic fatty liver disease that were randomized to the basic and control groups in the ratio of 2:1. …”
    Get full text
    Article
  20. 160